nodes	percent_of_prediction	percent_of_DWPC	metapath
Pseudoephedrine—IL2—acquired immunodeficiency syndrome	0.436	0.748	CbGaD
Pseudoephedrine—TNF—acquired immunodeficiency syndrome	0.147	0.252	CbGaD
Pseudoephedrine—CYP2D6—Efavirenz—acquired immunodeficiency syndrome	0.0256	0.137	CbGbCtD
Pseudoephedrine—CYP2D6—Lopinavir—acquired immunodeficiency syndrome	0.0241	0.129	CbGbCtD
Pseudoephedrine—CYP2D6—Nevirapine—acquired immunodeficiency syndrome	0.0241	0.129	CbGbCtD
Pseudoephedrine—CYP2D6—Amprenavir—acquired immunodeficiency syndrome	0.0218	0.116	CbGbCtD
Pseudoephedrine—CYP2D6—Delavirdine—acquired immunodeficiency syndrome	0.0218	0.116	CbGbCtD
Pseudoephedrine—CYP2D6—Indinavir—acquired immunodeficiency syndrome	0.0188	0.1	CbGbCtD
Pseudoephedrine—CYP2D6—Nelfinavir—acquired immunodeficiency syndrome	0.0183	0.0974	CbGbCtD
Pseudoephedrine—CYP2D6—Saquinavir—acquired immunodeficiency syndrome	0.0165	0.0881	CbGbCtD
Pseudoephedrine—CYP2D6—Ritonavir—acquired immunodeficiency syndrome	0.0165	0.0881	CbGbCtD
Pseudoephedrine—IL2—blood plasma—acquired immunodeficiency syndrome	0.00452	0.0794	CbGeAlD
Pseudoephedrine—Amphetamine—CARTPT—acquired immunodeficiency syndrome	0.00228	1	CrCbGaD
Pseudoephedrine—IL2—skin of body—acquired immunodeficiency syndrome	0.00217	0.0382	CbGeAlD
Pseudoephedrine—NFATC1—lymphoid tissue—acquired immunodeficiency syndrome	0.00193	0.0338	CbGeAlD
Pseudoephedrine—NFATC1—blood—acquired immunodeficiency syndrome	0.00181	0.0318	CbGeAlD
Pseudoephedrine—IL2—lymphoid tissue—acquired immunodeficiency syndrome	0.00176	0.0309	CbGeAlD
Pseudoephedrine—NFATC1—bone marrow—acquired immunodeficiency syndrome	0.00175	0.0308	CbGeAlD
Pseudoephedrine—IL2—digestive system—acquired immunodeficiency syndrome	0.00174	0.0305	CbGeAlD
Pseudoephedrine—TNF—blood—acquired immunodeficiency syndrome	0.00173	0.0303	CbGeAlD
Pseudoephedrine—IL2—blood—acquired immunodeficiency syndrome	0.00166	0.0291	CbGeAlD
Pseudoephedrine—IL2—bone marrow—acquired immunodeficiency syndrome	0.0016	0.0281	CbGeAlD
Pseudoephedrine—TNF—vagina—acquired immunodeficiency syndrome	0.0016	0.0281	CbGeAlD
Pseudoephedrine—NFATC1—lung—acquired immunodeficiency syndrome	0.00159	0.0279	CbGeAlD
Pseudoephedrine—SLC6A3—nerve—acquired immunodeficiency syndrome	0.00158	0.0277	CbGeAlD
Pseudoephedrine—NFATC1—nervous system—acquired immunodeficiency syndrome	0.00147	0.0258	CbGeAlD
Pseudoephedrine—IL2—lung—acquired immunodeficiency syndrome	0.00145	0.0255	CbGeAlD
Pseudoephedrine—NFATC1—central nervous system—acquired immunodeficiency syndrome	0.00142	0.0248	CbGeAlD
Pseudoephedrine—IL2—nervous system—acquired immunodeficiency syndrome	0.00135	0.0236	CbGeAlD
Pseudoephedrine—IL2—central nervous system—acquired immunodeficiency syndrome	0.0013	0.0227	CbGeAlD
Pseudoephedrine—SLC6A2—nerve—acquired immunodeficiency syndrome	0.00128	0.0224	CbGeAlD
Pseudoephedrine—MAOA—nerve—acquired immunodeficiency syndrome	0.00117	0.0206	CbGeAlD
Pseudoephedrine—NFATC1—brain—acquired immunodeficiency syndrome	0.00112	0.0197	CbGeAlD
Pseudoephedrine—SLC6A4—blood plasma—acquired immunodeficiency syndrome	0.0011	0.0192	CbGeAlD
Pseudoephedrine—NFATC1—lymph node—acquired immunodeficiency syndrome	0.00109	0.0191	CbGeAlD
Pseudoephedrine—TNF—lymph node—acquired immunodeficiency syndrome	0.00104	0.0182	CbGeAlD
Pseudoephedrine—IL2—brain—acquired immunodeficiency syndrome	0.00103	0.018	CbGeAlD
Pseudoephedrine—IL2—lymph node—acquired immunodeficiency syndrome	0.000994	0.0174	CbGeAlD
Pseudoephedrine—MAOA—blood plasma—acquired immunodeficiency syndrome	0.000889	0.0156	CbGeAlD
Pseudoephedrine—ADRA2A—blood plasma—acquired immunodeficiency syndrome	0.000682	0.012	CbGeAlD
Pseudoephedrine—CYP2D6—blood plasma—acquired immunodeficiency syndrome	0.000528	0.00926	CbGeAlD
Pseudoephedrine—MAOA—retina—acquired immunodeficiency syndrome	0.000487	0.00854	CbGeAlD
Pseudoephedrine—SLC6A3—spinal cord—acquired immunodeficiency syndrome	0.000422	0.0074	CbGeAlD
Pseudoephedrine—SLC6A4—digestive system—acquired immunodeficiency syndrome	0.000421	0.00739	CbGeAlD
Pseudoephedrine—SLC6A4—blood—acquired immunodeficiency syndrome	0.000401	0.00704	CbGeAlD
Pseudoephedrine—SLC6A4—spinal cord—acquired immunodeficiency syndrome	0.000387	0.00678	CbGeAlD
Pseudoephedrine—SLC6A3—lung—acquired immunodeficiency syndrome	0.000384	0.00673	CbGeAlD
Pseudoephedrine—ADRB1—lung—acquired immunodeficiency syndrome	0.000364	0.00639	CbGeAlD
Pseudoephedrine—SLC6A3—nervous system—acquired immunodeficiency syndrome	0.000355	0.00624	CbGeAlD
Pseudoephedrine—Tremor—Zidovudine—acquired immunodeficiency syndrome	0.000354	0.00417	CcSEcCtD
Pseudoephedrine—SLC6A4—lung—acquired immunodeficiency syndrome	0.000352	0.00617	CbGeAlD
Pseudoephedrine—Anorexia—Nevirapine—acquired immunodeficiency syndrome	0.00035	0.00413	CcSEcCtD
Pseudoephedrine—Pain—Didanosine—acquired immunodeficiency syndrome	0.00035	0.00412	CcSEcCtD
Pseudoephedrine—ADRA1A—lymphoid tissue—acquired immunodeficiency syndrome	0.000349	0.00612	CbGeAlD
Pseudoephedrine—Tension—Indinavir—acquired immunodeficiency syndrome	0.000345	0.00406	CcSEcCtD
Pseudoephedrine—Hyperhidrosis—Nelfinavir—acquired immunodeficiency syndrome	0.000344	0.00405	CcSEcCtD
Pseudoephedrine—Hyperhidrosis—Stavudine—acquired immunodeficiency syndrome	0.000343	0.00404	CcSEcCtD
Pseudoephedrine—SLC6A3—central nervous system—acquired immunodeficiency syndrome	0.000342	0.006	CbGeAlD
Pseudoephedrine—MAOA—digestive system—acquired immunodeficiency syndrome	0.000342	0.00599	CbGeAlD
Pseudoephedrine—Nervousness—Indinavir—acquired immunodeficiency syndrome	0.000341	0.00402	CcSEcCtD
Pseudoephedrine—Arrhythmia—Efavirenz—acquired immunodeficiency syndrome	0.000341	0.00401	CcSEcCtD
Pseudoephedrine—Vertigo—Zidovudine—acquired immunodeficiency syndrome	0.00034	0.004	CcSEcCtD
Pseudoephedrine—Anorexia—Nelfinavir—acquired immunodeficiency syndrome	0.000339	0.004	CcSEcCtD
Pseudoephedrine—Anorexia—Stavudine—acquired immunodeficiency syndrome	0.000338	0.00399	CcSEcCtD
Pseudoephedrine—Muscle spasms—Indinavir—acquired immunodeficiency syndrome	0.000338	0.00398	CcSEcCtD
Pseudoephedrine—ADRB1—nervous system—acquired immunodeficiency syndrome	0.000337	0.00592	CbGeAlD
Pseudoephedrine—Hallucination—Ritonavir—acquired immunodeficiency syndrome	0.000336	0.00396	CcSEcCtD
Pseudoephedrine—Anorexia—Abacavir—acquired immunodeficiency syndrome	0.000333	0.00393	CcSEcCtD
Pseudoephedrine—Sweating—Lamivudine—acquired immunodeficiency syndrome	0.000331	0.0039	CcSEcCtD
Pseudoephedrine—Tremor—Indinavir—acquired immunodeficiency syndrome	0.000329	0.00388	CcSEcCtD
Pseudoephedrine—ADRA1A—blood—acquired immunodeficiency syndrome	0.000328	0.00576	CbGeAlD
Pseudoephedrine—Tension—Efavirenz—acquired immunodeficiency syndrome	0.000326	0.00384	CcSEcCtD
Pseudoephedrine—SLC6A4—nervous system—acquired immunodeficiency syndrome	0.000326	0.00572	CbGeAlD
Pseudoephedrine—MAOA—blood—acquired immunodeficiency syndrome	0.000325	0.00571	CbGeAlD
Pseudoephedrine—ADRB1—central nervous system—acquired immunodeficiency syndrome	0.000325	0.0057	CbGeAlD
Pseudoephedrine—Hallucination—Saquinavir—acquired immunodeficiency syndrome	0.000323	0.00381	CcSEcCtD
Pseudoephedrine—Body temperature increased—Didanosine—acquired immunodeficiency syndrome	0.000323	0.00381	CcSEcCtD
Pseudoephedrine—Agitation—Indinavir—acquired immunodeficiency syndrome	0.000323	0.00381	CcSEcCtD
Pseudoephedrine—Nervousness—Efavirenz—acquired immunodeficiency syndrome	0.000323	0.0038	CcSEcCtD
Pseudoephedrine—Insomnia—Nelfinavir—acquired immunodeficiency syndrome	0.000322	0.00379	CcSEcCtD
Pseudoephedrine—Chest pain—Zidovudine—acquired immunodeficiency syndrome	0.000322	0.00379	CcSEcCtD
Pseudoephedrine—Asthenia—Amprenavir—acquired immunodeficiency syndrome	0.000322	0.00379	CcSEcCtD
Pseudoephedrine—Insomnia—Stavudine—acquired immunodeficiency syndrome	0.000321	0.00378	CcSEcCtD
Pseudoephedrine—Anxiety—Zidovudine—acquired immunodeficiency syndrome	0.000321	0.00378	CcSEcCtD
Pseudoephedrine—Decreased appetite—Nevirapine—acquired immunodeficiency syndrome	0.00032	0.00376	CcSEcCtD
Pseudoephedrine—Dyspnoea—Nelfinavir—acquired immunodeficiency syndrome	0.000317	0.00374	CcSEcCtD
Pseudoephedrine—Insomnia—Abacavir—acquired immunodeficiency syndrome	0.000316	0.00373	CcSEcCtD
Pseudoephedrine—Vertigo—Indinavir—acquired immunodeficiency syndrome	0.000316	0.00372	CcSEcCtD
Pseudoephedrine—Pain—Nevirapine—acquired immunodeficiency syndrome	0.000314	0.0037	CcSEcCtD
Pseudoephedrine—SLC6A4—central nervous system—acquired immunodeficiency syndrome	0.000314	0.0055	CbGeAlD
Pseudoephedrine—MAOA—spinal cord—acquired immunodeficiency syndrome	0.000314	0.0055	CbGeAlD
Pseudoephedrine—Dyspepsia—Nelfinavir—acquired immunodeficiency syndrome	0.000313	0.00369	CcSEcCtD
Pseudoephedrine—Dyspepsia—Stavudine—acquired immunodeficiency syndrome	0.000312	0.00368	CcSEcCtD
Pseudoephedrine—Tension—Delavirdine—acquired immunodeficiency syndrome	0.000312	0.00367	CcSEcCtD
Pseudoephedrine—Dyspnoea—Abacavir—acquired immunodeficiency syndrome	0.000312	0.00367	CcSEcCtD
Pseudoephedrine—Tremor—Efavirenz—acquired immunodeficiency syndrome	0.000311	0.00367	CcSEcCtD
Pseudoephedrine—Confusional state—Zidovudine—acquired immunodeficiency syndrome	0.000311	0.00366	CcSEcCtD
Pseudoephedrine—Palpitations—Indinavir—acquired immunodeficiency syndrome	0.000311	0.00366	CcSEcCtD
Pseudoephedrine—SLC6A2—lung—acquired immunodeficiency syndrome	0.00031	0.00543	CbGeAlD
Pseudoephedrine—Decreased appetite—Nelfinavir—acquired immunodeficiency syndrome	0.00031	0.00365	CcSEcCtD
Pseudoephedrine—Nervousness—Delavirdine—acquired immunodeficiency syndrome	0.000309	0.00364	CcSEcCtD
Pseudoephedrine—Decreased appetite—Stavudine—acquired immunodeficiency syndrome	0.000309	0.00363	CcSEcCtD
Pseudoephedrine—Muscle spasms—Delavirdine—acquired immunodeficiency syndrome	0.000306	0.0036	CcSEcCtD
Pseudoephedrine—Agitation—Efavirenz—acquired immunodeficiency syndrome	0.000305	0.0036	CcSEcCtD
Pseudoephedrine—Pain—Nelfinavir—acquired immunodeficiency syndrome	0.000304	0.00359	CcSEcCtD
Pseudoephedrine—Decreased appetite—Abacavir—acquired immunodeficiency syndrome	0.000304	0.00358	CcSEcCtD
Pseudoephedrine—Pain—Stavudine—acquired immunodeficiency syndrome	0.000304	0.00358	CcSEcCtD
Pseudoephedrine—Feeling abnormal—Nevirapine—acquired immunodeficiency syndrome	0.000303	0.00357	CcSEcCtD
Pseudoephedrine—MAOA—vagina—acquired immunodeficiency syndrome	0.000302	0.00529	CbGeAlD
Pseudoephedrine—Chest pain—Indinavir—acquired immunodeficiency syndrome	0.000299	0.00353	CcSEcCtD
Pseudoephedrine—Pain—Abacavir—acquired immunodeficiency syndrome	0.000299	0.00352	CcSEcCtD
Pseudoephedrine—Vertigo—Efavirenz—acquired immunodeficiency syndrome	0.000298	0.00352	CcSEcCtD
Pseudoephedrine—Anxiety—Indinavir—acquired immunodeficiency syndrome	0.000298	0.00351	CcSEcCtD
Pseudoephedrine—Hyperhidrosis—Zidovudine—acquired immunodeficiency syndrome	0.000298	0.00351	CcSEcCtD
Pseudoephedrine—Tremor—Delavirdine—acquired immunodeficiency syndrome	0.000298	0.00351	CcSEcCtD
Pseudoephedrine—Anorexia—Zidovudine—acquired immunodeficiency syndrome	0.000294	0.00346	CcSEcCtD
Pseudoephedrine—Palpitations—Efavirenz—acquired immunodeficiency syndrome	0.000294	0.00346	CcSEcCtD
Pseudoephedrine—Feeling abnormal—Nelfinavir—acquired immunodeficiency syndrome	0.000293	0.00346	CcSEcCtD
Pseudoephedrine—Asthenia—Didanosine—acquired immunodeficiency syndrome	0.000293	0.00346	CcSEcCtD
Pseudoephedrine—Agitation—Delavirdine—acquired immunodeficiency syndrome	0.000292	0.00344	CcSEcCtD
Pseudoephedrine—Body temperature increased—Nevirapine—acquired immunodeficiency syndrome	0.000291	0.00342	CcSEcCtD
Pseudoephedrine—Tension—Ritonavir—acquired immunodeficiency syndrome	0.000288	0.0034	CcSEcCtD
Pseudoephedrine—Feeling abnormal—Abacavir—acquired immunodeficiency syndrome	0.000288	0.00339	CcSEcCtD
Pseudoephedrine—Hypertension—Efavirenz—acquired immunodeficiency syndrome	0.000287	0.00338	CcSEcCtD
Pseudoephedrine—SLC6A2—nervous system—acquired immunodeficiency syndrome	0.000287	0.00503	CbGeAlD
Pseudoephedrine—Vertigo—Delavirdine—acquired immunodeficiency syndrome	0.000286	0.00336	CcSEcCtD
Pseudoephedrine—Nervousness—Ritonavir—acquired immunodeficiency syndrome	0.000285	0.00336	CcSEcCtD
Pseudoephedrine—MAOA—lung—acquired immunodeficiency syndrome	0.000285	0.00501	CbGeAlD
Pseudoephedrine—Vomiting—Amprenavir—acquired immunodeficiency syndrome	0.000285	0.00336	CcSEcCtD
Pseudoephedrine—Chest pain—Efavirenz—acquired immunodeficiency syndrome	0.000283	0.00333	CcSEcCtD
Pseudoephedrine—Rash—Amprenavir—acquired immunodeficiency syndrome	0.000283	0.00333	CcSEcCtD
Pseudoephedrine—Muscle spasms—Ritonavir—acquired immunodeficiency syndrome	0.000283	0.00333	CcSEcCtD
Pseudoephedrine—Dermatitis—Amprenavir—acquired immunodeficiency syndrome	0.000283	0.00333	CcSEcCtD
Pseudoephedrine—Anxiety—Efavirenz—acquired immunodeficiency syndrome	0.000282	0.00332	CcSEcCtD
Pseudoephedrine—Body temperature increased—Nelfinavir—acquired immunodeficiency syndrome	0.000281	0.00332	CcSEcCtD
Pseudoephedrine—Headache—Amprenavir—acquired immunodeficiency syndrome	0.000281	0.00331	CcSEcCtD
Pseudoephedrine—Palpitations—Delavirdine—acquired immunodeficiency syndrome	0.000281	0.00331	CcSEcCtD
Pseudoephedrine—Body temperature increased—Stavudine—acquired immunodeficiency syndrome	0.000281	0.00331	CcSEcCtD
Pseudoephedrine—Insomnia—Zidovudine—acquired immunodeficiency syndrome	0.000279	0.00329	CcSEcCtD
Pseudoephedrine—Hyperhidrosis—Indinavir—acquired immunodeficiency syndrome	0.000277	0.00327	CcSEcCtD
Pseudoephedrine—Body temperature increased—Abacavir—acquired immunodeficiency syndrome	0.000276	0.00326	CcSEcCtD
Pseudoephedrine—SLC6A2—central nervous system—acquired immunodeficiency syndrome	0.000276	0.00484	CbGeAlD
Pseudoephedrine—Tremor—Ritonavir—acquired immunodeficiency syndrome	0.000275	0.00324	CcSEcCtD
Pseudoephedrine—Dyspnoea—Zidovudine—acquired immunodeficiency syndrome	0.000275	0.00324	CcSEcCtD
Pseudoephedrine—Hypertension—Delavirdine—acquired immunodeficiency syndrome	0.000274	0.00323	CcSEcCtD
Pseudoephedrine—Anorexia—Indinavir—acquired immunodeficiency syndrome	0.000274	0.00322	CcSEcCtD
Pseudoephedrine—Confusional state—Efavirenz—acquired immunodeficiency syndrome	0.000273	0.00322	CcSEcCtD
Pseudoephedrine—Muscle spasms—Saquinavir—acquired immunodeficiency syndrome	0.000272	0.0032	CcSEcCtD
Pseudoephedrine—SLC6A3—brain—acquired immunodeficiency syndrome	0.000272	0.00477	CbGeAlD
Pseudoephedrine—Dyspepsia—Zidovudine—acquired immunodeficiency syndrome	0.000272	0.0032	CcSEcCtD
Pseudoephedrine—Chest pain—Delavirdine—acquired immunodeficiency syndrome	0.000271	0.00319	CcSEcCtD
Pseudoephedrine—Agitation—Ritonavir—acquired immunodeficiency syndrome	0.00027	0.00318	CcSEcCtD
Pseudoephedrine—Anxiety—Delavirdine—acquired immunodeficiency syndrome	0.00027	0.00318	CcSEcCtD
Pseudoephedrine—Decreased appetite—Zidovudine—acquired immunodeficiency syndrome	0.000268	0.00316	CcSEcCtD
Pseudoephedrine—ADRA1A—nervous system—acquired immunodeficiency syndrome	0.000267	0.00468	CbGeAlD
Pseudoephedrine—Nausea—Amprenavir—acquired immunodeficiency syndrome	0.000266	0.00314	CcSEcCtD
Pseudoephedrine—Tremor—Saquinavir—acquired immunodeficiency syndrome	0.000265	0.00312	CcSEcCtD
Pseudoephedrine—Tension—Lamivudine—acquired immunodeficiency syndrome	0.000265	0.00312	CcSEcCtD
Pseudoephedrine—Tachycardia—Efavirenz—acquired immunodeficiency syndrome	0.000265	0.00312	CcSEcCtD
Pseudoephedrine—MAOA—nervous system—acquired immunodeficiency syndrome	0.000264	0.00464	CbGeAlD
Pseudoephedrine—Vertigo—Ritonavir—acquired immunodeficiency syndrome	0.000264	0.00311	CcSEcCtD
Pseudoephedrine—Pain—Zidovudine—acquired immunodeficiency syndrome	0.000264	0.00311	CcSEcCtD
Pseudoephedrine—Asthenia—Nevirapine—acquired immunodeficiency syndrome	0.000264	0.00311	CcSEcCtD
Pseudoephedrine—Nervousness—Lamivudine—acquired immunodeficiency syndrome	0.000262	0.00309	CcSEcCtD
Pseudoephedrine—Hyperhidrosis—Efavirenz—acquired immunodeficiency syndrome	0.000262	0.00309	CcSEcCtD
Pseudoephedrine—Confusional state—Delavirdine—acquired immunodeficiency syndrome	0.000262	0.00308	CcSEcCtD
Pseudoephedrine—Vomiting—Didanosine—acquired immunodeficiency syndrome	0.00026	0.00306	CcSEcCtD
Pseudoephedrine—Agitation—Saquinavir—acquired immunodeficiency syndrome	0.00026	0.00306	CcSEcCtD
Pseudoephedrine—Palpitations—Ritonavir—acquired immunodeficiency syndrome	0.00026	0.00306	CcSEcCtD
Pseudoephedrine—Insomnia—Indinavir—acquired immunodeficiency syndrome	0.00026	0.00306	CcSEcCtD
Pseudoephedrine—Muscle spasms—Lamivudine—acquired immunodeficiency syndrome	0.000259	0.00306	CcSEcCtD
Pseudoephedrine—Anorexia—Efavirenz—acquired immunodeficiency syndrome	0.000258	0.00304	CcSEcCtD
Pseudoephedrine—Rash—Didanosine—acquired immunodeficiency syndrome	0.000258	0.00304	CcSEcCtD
Pseudoephedrine—ADRB1—brain—acquired immunodeficiency syndrome	0.000258	0.00452	CbGeAlD
Pseudoephedrine—Dermatitis—Didanosine—acquired immunodeficiency syndrome	0.000258	0.00303	CcSEcCtD
Pseudoephedrine—ADRA1A—central nervous system—acquired immunodeficiency syndrome	0.000257	0.0045	CbGeAlD
Pseudoephedrine—Headache—Didanosine—acquired immunodeficiency syndrome	0.000256	0.00302	CcSEcCtD
Pseudoephedrine—Dyspnoea—Indinavir—acquired immunodeficiency syndrome	0.000256	0.00301	CcSEcCtD
Pseudoephedrine—Asthenia—Nelfinavir—acquired immunodeficiency syndrome	0.000255	0.00301	CcSEcCtD
Pseudoephedrine—Asthenia—Stavudine—acquired immunodeficiency syndrome	0.000255	0.003	CcSEcCtD
Pseudoephedrine—MAOA—central nervous system—acquired immunodeficiency syndrome	0.000254	0.00446	CbGeAlD
Pseudoephedrine—Feeling abnormal—Zidovudine—acquired immunodeficiency syndrome	0.000254	0.00299	CcSEcCtD
Pseudoephedrine—Vertigo—Saquinavir—acquired immunodeficiency syndrome	0.000254	0.00299	CcSEcCtD
Pseudoephedrine—Hypertension—Ritonavir—acquired immunodeficiency syndrome	0.000254	0.00299	CcSEcCtD
Pseudoephedrine—Tachycardia—Delavirdine—acquired immunodeficiency syndrome	0.000253	0.00298	CcSEcCtD
Pseudoephedrine—Tremor—Lamivudine—acquired immunodeficiency syndrome	0.000253	0.00298	CcSEcCtD
Pseudoephedrine—Dyspepsia—Indinavir—acquired immunodeficiency syndrome	0.000253	0.00297	CcSEcCtD
Pseudoephedrine—Asthenia—Abacavir—acquired immunodeficiency syndrome	0.000251	0.00296	CcSEcCtD
Pseudoephedrine—Hyperhidrosis—Delavirdine—acquired immunodeficiency syndrome	0.000251	0.00295	CcSEcCtD
Pseudoephedrine—Chest pain—Ritonavir—acquired immunodeficiency syndrome	0.00025	0.00295	CcSEcCtD
Pseudoephedrine—ADRA2A—blood—acquired immunodeficiency syndrome	0.00025	0.00438	CbGeAlD
Pseudoephedrine—Decreased appetite—Indinavir—acquired immunodeficiency syndrome	0.000249	0.00294	CcSEcCtD
Pseudoephedrine—Anxiety—Ritonavir—acquired immunodeficiency syndrome	0.000249	0.00294	CcSEcCtD
Pseudoephedrine—SLC6A4—brain—acquired immunodeficiency syndrome	0.000249	0.00437	CbGeAlD
Pseudoephedrine—Anorexia—Delavirdine—acquired immunodeficiency syndrome	0.000247	0.00291	CcSEcCtD
Pseudoephedrine—Pain—Indinavir—acquired immunodeficiency syndrome	0.000245	0.00289	CcSEcCtD
Pseudoephedrine—Insomnia—Efavirenz—acquired immunodeficiency syndrome	0.000245	0.00289	CcSEcCtD
Pseudoephedrine—Hypertension—Saquinavir—acquired immunodeficiency syndrome	0.000244	0.00288	CcSEcCtD
Pseudoephedrine—Body temperature increased—Zidovudine—acquired immunodeficiency syndrome	0.000244	0.00287	CcSEcCtD
Pseudoephedrine—Nausea—Didanosine—acquired immunodeficiency syndrome	0.000243	0.00286	CcSEcCtD
Pseudoephedrine—Vertigo—Lamivudine—acquired immunodeficiency syndrome	0.000242	0.00286	CcSEcCtD
Pseudoephedrine—Confusional state—Ritonavir—acquired immunodeficiency syndrome	0.000242	0.00285	CcSEcCtD
Pseudoephedrine—Dyspnoea—Efavirenz—acquired immunodeficiency syndrome	0.000242	0.00285	CcSEcCtD
Pseudoephedrine—Chest pain—Saquinavir—acquired immunodeficiency syndrome	0.000241	0.00284	CcSEcCtD
Pseudoephedrine—ADRA2A—spinal cord—acquired immunodeficiency syndrome	0.000241	0.00422	CbGeAlD
Pseudoephedrine—Anxiety—Saquinavir—acquired immunodeficiency syndrome	0.00024	0.00283	CcSEcCtD
Pseudoephedrine—Dyspepsia—Efavirenz—acquired immunodeficiency syndrome	0.000239	0.00281	CcSEcCtD
Pseudoephedrine—Feeling abnormal—Indinavir—acquired immunodeficiency syndrome	0.000236	0.00278	CcSEcCtD
Pseudoephedrine—Decreased appetite—Efavirenz—acquired immunodeficiency syndrome	0.000236	0.00278	CcSEcCtD
Pseudoephedrine—Dizziness—Nelfinavir—acquired immunodeficiency syndrome	0.000235	0.00277	CcSEcCtD
Pseudoephedrine—Dizziness—Stavudine—acquired immunodeficiency syndrome	0.000235	0.00276	CcSEcCtD
Pseudoephedrine—Insomnia—Delavirdine—acquired immunodeficiency syndrome	0.000235	0.00276	CcSEcCtD
Pseudoephedrine—Tachycardia—Ritonavir—acquired immunodeficiency syndrome	0.000234	0.00276	CcSEcCtD
Pseudoephedrine—Vomiting—Nevirapine—acquired immunodeficiency syndrome	0.000234	0.00275	CcSEcCtD
Pseudoephedrine—Confusional state—Saquinavir—acquired immunodeficiency syndrome	0.000233	0.00274	CcSEcCtD
Pseudoephedrine—Hyperhidrosis—Ritonavir—acquired immunodeficiency syndrome	0.000232	0.00273	CcSEcCtD
Pseudoephedrine—Pain—Efavirenz—acquired immunodeficiency syndrome	0.000232	0.00273	CcSEcCtD
Pseudoephedrine—Rash—Nevirapine—acquired immunodeficiency syndrome	0.000232	0.00273	CcSEcCtD
Pseudoephedrine—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	0.000232	0.00273	CcSEcCtD
Pseudoephedrine—ADRA2A—vagina—acquired immunodeficiency syndrome	0.000231	0.00406	CbGeAlD
Pseudoephedrine—Dyspnoea—Delavirdine—acquired immunodeficiency syndrome	0.000231	0.00272	CcSEcCtD
Pseudoephedrine—Dizziness—Abacavir—acquired immunodeficiency syndrome	0.000231	0.00272	CcSEcCtD
Pseudoephedrine—Headache—Nevirapine—acquired immunodeficiency syndrome	0.00023	0.00271	CcSEcCtD
Pseudoephedrine—Chest pain—Lamivudine—acquired immunodeficiency syndrome	0.00023	0.00271	CcSEcCtD
Pseudoephedrine—Anxiety—Lamivudine—acquired immunodeficiency syndrome	0.000229	0.0027	CcSEcCtD
Pseudoephedrine—Anorexia—Ritonavir—acquired immunodeficiency syndrome	0.000229	0.00269	CcSEcCtD
Pseudoephedrine—Dyspepsia—Delavirdine—acquired immunodeficiency syndrome	0.000228	0.00269	CcSEcCtD
Pseudoephedrine—Body temperature increased—Indinavir—acquired immunodeficiency syndrome	0.000227	0.00267	CcSEcCtD
Pseudoephedrine—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	0.000226	0.00267	CcSEcCtD
Pseudoephedrine—Vomiting—Stavudine—acquired immunodeficiency syndrome	0.000226	0.00266	CcSEcCtD
Pseudoephedrine—Decreased appetite—Delavirdine—acquired immunodeficiency syndrome	0.000225	0.00266	CcSEcCtD
Pseudoephedrine—Rash—Nelfinavir—acquired immunodeficiency syndrome	0.000225	0.00264	CcSEcCtD
Pseudoephedrine—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	0.000224	0.00264	CcSEcCtD
Pseudoephedrine—Rash—Stavudine—acquired immunodeficiency syndrome	0.000224	0.00264	CcSEcCtD
Pseudoephedrine—Dermatitis—Stavudine—acquired immunodeficiency syndrome	0.000224	0.00263	CcSEcCtD
Pseudoephedrine—Feeling abnormal—Efavirenz—acquired immunodeficiency syndrome	0.000223	0.00263	CcSEcCtD
Pseudoephedrine—Hyperhidrosis—Saquinavir—acquired immunodeficiency syndrome	0.000223	0.00263	CcSEcCtD
Pseudoephedrine—Headache—Nelfinavir—acquired immunodeficiency syndrome	0.000223	0.00263	CcSEcCtD
Pseudoephedrine—Headache—Stavudine—acquired immunodeficiency syndrome	0.000222	0.00262	CcSEcCtD
Pseudoephedrine—Vomiting—Abacavir—acquired immunodeficiency syndrome	0.000222	0.00262	CcSEcCtD
Pseudoephedrine—Confusional state—Lamivudine—acquired immunodeficiency syndrome	0.000222	0.00262	CcSEcCtD
Pseudoephedrine—Pain—Delavirdine—acquired immunodeficiency syndrome	0.000222	0.00261	CcSEcCtD
Pseudoephedrine—Asthenia—Zidovudine—acquired immunodeficiency syndrome	0.000221	0.00261	CcSEcCtD
Pseudoephedrine—Rash—Abacavir—acquired immunodeficiency syndrome	0.00022	0.0026	CcSEcCtD
Pseudoephedrine—Dermatitis—Abacavir—acquired immunodeficiency syndrome	0.00022	0.00259	CcSEcCtD
Pseudoephedrine—Anorexia—Saquinavir—acquired immunodeficiency syndrome	0.00022	0.00259	CcSEcCtD
Pseudoephedrine—SLC6A2—brain—acquired immunodeficiency syndrome	0.000219	0.00385	CbGeAlD
Pseudoephedrine—Headache—Abacavir—acquired immunodeficiency syndrome	0.000219	0.00258	CcSEcCtD
Pseudoephedrine—ADRA2A—lung—acquired immunodeficiency syndrome	0.000219	0.00384	CbGeAlD
Pseudoephedrine—Nausea—Nevirapine—acquired immunodeficiency syndrome	0.000218	0.00257	CcSEcCtD
Pseudoephedrine—Insomnia—Ritonavir—acquired immunodeficiency syndrome	0.000217	0.00256	CcSEcCtD
Pseudoephedrine—Body temperature increased—Efavirenz—acquired immunodeficiency syndrome	0.000214	0.00252	CcSEcCtD
Pseudoephedrine—Dyspnoea—Ritonavir—acquired immunodeficiency syndrome	0.000214	0.00252	CcSEcCtD
Pseudoephedrine—Feeling abnormal—Delavirdine—acquired immunodeficiency syndrome	0.000214	0.00252	CcSEcCtD
Pseudoephedrine—Hyperhidrosis—Lamivudine—acquired immunodeficiency syndrome	0.000213	0.00251	CcSEcCtD
Pseudoephedrine—SLC6A2—lymph node—acquired immunodeficiency syndrome	0.000212	0.00372	CbGeAlD
Pseudoephedrine—Nausea—Nelfinavir—acquired immunodeficiency syndrome	0.000212	0.00249	CcSEcCtD
Pseudoephedrine—Dyspepsia—Ritonavir—acquired immunodeficiency syndrome	0.000211	0.00249	CcSEcCtD
Pseudoephedrine—Nausea—Stavudine—acquired immunodeficiency syndrome	0.000211	0.00248	CcSEcCtD
Pseudoephedrine—Anorexia—Lamivudine—acquired immunodeficiency syndrome	0.00021	0.00247	CcSEcCtD
Pseudoephedrine—Insomnia—Saquinavir—acquired immunodeficiency syndrome	0.000209	0.00246	CcSEcCtD
Pseudoephedrine—Decreased appetite—Ritonavir—acquired immunodeficiency syndrome	0.000209	0.00246	CcSEcCtD
Pseudoephedrine—Nausea—Abacavir—acquired immunodeficiency syndrome	0.000208	0.00245	CcSEcCtD
Pseudoephedrine—Asthenia—Indinavir—acquired immunodeficiency syndrome	0.000206	0.00242	CcSEcCtD
Pseudoephedrine—Dyspnoea—Saquinavir—acquired immunodeficiency syndrome	0.000206	0.00242	CcSEcCtD
Pseudoephedrine—Pain—Ritonavir—acquired immunodeficiency syndrome	0.000205	0.00242	CcSEcCtD
Pseudoephedrine—Body temperature increased—Delavirdine—acquired immunodeficiency syndrome	0.000205	0.00242	CcSEcCtD
Pseudoephedrine—Dizziness—Zidovudine—acquired immunodeficiency syndrome	0.000204	0.0024	CcSEcCtD
Pseudoephedrine—ADRA1A—brain—acquired immunodeficiency syndrome	0.000204	0.00358	CbGeAlD
Pseudoephedrine—Dyspepsia—Saquinavir—acquired immunodeficiency syndrome	0.000203	0.00239	CcSEcCtD
Pseudoephedrine—CYP2D6—digestive system—acquired immunodeficiency syndrome	0.000203	0.00356	CbGeAlD
Pseudoephedrine—ADRA2A—nervous system—acquired immunodeficiency syndrome	0.000203	0.00356	CbGeAlD
Pseudoephedrine—MAOA—brain—acquired immunodeficiency syndrome	0.000202	0.00354	CbGeAlD
Pseudoephedrine—Decreased appetite—Saquinavir—acquired immunodeficiency syndrome	0.000201	0.00236	CcSEcCtD
Pseudoephedrine—Insomnia—Lamivudine—acquired immunodeficiency syndrome	0.000199	0.00235	CcSEcCtD
Pseudoephedrine—Feeling abnormal—Ritonavir—acquired immunodeficiency syndrome	0.000198	0.00233	CcSEcCtD
Pseudoephedrine—Pain—Saquinavir—acquired immunodeficiency syndrome	0.000197	0.00233	CcSEcCtD
Pseudoephedrine—Dyspnoea—Lamivudine—acquired immunodeficiency syndrome	0.000196	0.00231	CcSEcCtD
Pseudoephedrine—Vomiting—Zidovudine—acquired immunodeficiency syndrome	0.000196	0.00231	CcSEcCtD
Pseudoephedrine—ADRA2A—central nervous system—acquired immunodeficiency syndrome	0.000195	0.00342	CbGeAlD
Pseudoephedrine—MAOA—lymph node—acquired immunodeficiency syndrome	0.000195	0.00342	CbGeAlD
Pseudoephedrine—Rash—Zidovudine—acquired immunodeficiency syndrome	0.000195	0.00229	CcSEcCtD
Pseudoephedrine—Asthenia—Efavirenz—acquired immunodeficiency syndrome	0.000195	0.00229	CcSEcCtD
Pseudoephedrine—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	0.000194	0.00229	CcSEcCtD
Pseudoephedrine—Dyspepsia—Lamivudine—acquired immunodeficiency syndrome	0.000194	0.00228	CcSEcCtD
Pseudoephedrine—CYP2D6—blood—acquired immunodeficiency syndrome	0.000193	0.00339	CbGeAlD
Pseudoephedrine—Headache—Zidovudine—acquired immunodeficiency syndrome	0.000193	0.00228	CcSEcCtD
Pseudoephedrine—Decreased appetite—Lamivudine—acquired immunodeficiency syndrome	0.000191	0.00225	CcSEcCtD
Pseudoephedrine—Feeling abnormal—Saquinavir—acquired immunodeficiency syndrome	0.00019	0.00224	CcSEcCtD
Pseudoephedrine—Dizziness—Indinavir—acquired immunodeficiency syndrome	0.00019	0.00223	CcSEcCtD
Pseudoephedrine—Body temperature increased—Ritonavir—acquired immunodeficiency syndrome	0.00019	0.00223	CcSEcCtD
Pseudoephedrine—Pain—Lamivudine—acquired immunodeficiency syndrome	0.000188	0.00222	CcSEcCtD
Pseudoephedrine—Asthenia—Delavirdine—acquired immunodeficiency syndrome	0.000186	0.00219	CcSEcCtD
Pseudoephedrine—Nausea—Zidovudine—acquired immunodeficiency syndrome	0.000183	0.00216	CcSEcCtD
Pseudoephedrine—Body temperature increased—Saquinavir—acquired immunodeficiency syndrome	0.000183	0.00215	CcSEcCtD
Pseudoephedrine—Vomiting—Indinavir—acquired immunodeficiency syndrome	0.000182	0.00215	CcSEcCtD
Pseudoephedrine—Feeling abnormal—Lamivudine—acquired immunodeficiency syndrome	0.000182	0.00214	CcSEcCtD
Pseudoephedrine—Rash—Indinavir—acquired immunodeficiency syndrome	0.000181	0.00213	CcSEcCtD
Pseudoephedrine—Dermatitis—Indinavir—acquired immunodeficiency syndrome	0.000181	0.00213	CcSEcCtD
Pseudoephedrine—Headache—Indinavir—acquired immunodeficiency syndrome	0.00018	0.00212	CcSEcCtD
Pseudoephedrine—Dizziness—Efavirenz—acquired immunodeficiency syndrome	0.000179	0.00211	CcSEcCtD
Pseudoephedrine—Body temperature increased—Lamivudine—acquired immunodeficiency syndrome	0.000174	0.00205	CcSEcCtD
Pseudoephedrine—Vomiting—Efavirenz—acquired immunodeficiency syndrome	0.000172	0.00203	CcSEcCtD
Pseudoephedrine—Asthenia—Ritonavir—acquired immunodeficiency syndrome	0.000172	0.00203	CcSEcCtD
Pseudoephedrine—Dizziness—Delavirdine—acquired immunodeficiency syndrome	0.000172	0.00202	CcSEcCtD
Pseudoephedrine—Rash—Efavirenz—acquired immunodeficiency syndrome	0.000171	0.00201	CcSEcCtD
Pseudoephedrine—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	0.000171	0.00201	CcSEcCtD
Pseudoephedrine—Nausea—Indinavir—acquired immunodeficiency syndrome	0.00017	0.00201	CcSEcCtD
Pseudoephedrine—Headache—Efavirenz—acquired immunodeficiency syndrome	0.00017	0.002	CcSEcCtD
Pseudoephedrine—Asthenia—Saquinavir—acquired immunodeficiency syndrome	0.000166	0.00195	CcSEcCtD
Pseudoephedrine—Vomiting—Delavirdine—acquired immunodeficiency syndrome	0.000165	0.00194	CcSEcCtD
Pseudoephedrine—Rash—Delavirdine—acquired immunodeficiency syndrome	0.000164	0.00193	CcSEcCtD
Pseudoephedrine—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	0.000163	0.00192	CcSEcCtD
Pseudoephedrine—Headache—Delavirdine—acquired immunodeficiency syndrome	0.000163	0.00191	CcSEcCtD
Pseudoephedrine—Nausea—Efavirenz—acquired immunodeficiency syndrome	0.000161	0.0019	CcSEcCtD
Pseudoephedrine—Dizziness—Ritonavir—acquired immunodeficiency syndrome	0.000159	0.00187	CcSEcCtD
Pseudoephedrine—Asthenia—Lamivudine—acquired immunodeficiency syndrome	0.000158	0.00186	CcSEcCtD
Pseudoephedrine—CYP2D6—nervous system—acquired immunodeficiency syndrome	0.000157	0.00275	CbGeAlD
Pseudoephedrine—ADRA2A—brain—acquired immunodeficiency syndrome	0.000155	0.00272	CbGeAlD
Pseudoephedrine—Nausea—Delavirdine—acquired immunodeficiency syndrome	0.000154	0.00181	CcSEcCtD
Pseudoephedrine—Dizziness—Saquinavir—acquired immunodeficiency syndrome	0.000153	0.0018	CcSEcCtD
Pseudoephedrine—Vomiting—Ritonavir—acquired immunodeficiency syndrome	0.000153	0.0018	CcSEcCtD
Pseudoephedrine—Rash—Ritonavir—acquired immunodeficiency syndrome	0.000151	0.00178	CcSEcCtD
Pseudoephedrine—CYP2D6—central nervous system—acquired immunodeficiency syndrome	0.000151	0.00265	CbGeAlD
Pseudoephedrine—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	0.000151	0.00178	CcSEcCtD
Pseudoephedrine—Headache—Ritonavir—acquired immunodeficiency syndrome	0.00015	0.00177	CcSEcCtD
Pseudoephedrine—ADRA2A—lymph node—acquired immunodeficiency syndrome	0.00015	0.00263	CbGeAlD
Pseudoephedrine—Vomiting—Saquinavir—acquired immunodeficiency syndrome	0.000147	0.00173	CcSEcCtD
Pseudoephedrine—Dizziness—Lamivudine—acquired immunodeficiency syndrome	0.000146	0.00172	CcSEcCtD
Pseudoephedrine—Rash—Saquinavir—acquired immunodeficiency syndrome	0.000146	0.00171	CcSEcCtD
Pseudoephedrine—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	0.000145	0.00171	CcSEcCtD
Pseudoephedrine—Headache—Saquinavir—acquired immunodeficiency syndrome	0.000145	0.0017	CcSEcCtD
Pseudoephedrine—Nausea—Ritonavir—acquired immunodeficiency syndrome	0.000142	0.00168	CcSEcCtD
Pseudoephedrine—Vomiting—Lamivudine—acquired immunodeficiency syndrome	0.00014	0.00165	CcSEcCtD
Pseudoephedrine—Rash—Lamivudine—acquired immunodeficiency syndrome	0.000139	0.00164	CcSEcCtD
Pseudoephedrine—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	0.000139	0.00163	CcSEcCtD
Pseudoephedrine—Headache—Lamivudine—acquired immunodeficiency syndrome	0.000138	0.00163	CcSEcCtD
Pseudoephedrine—Nausea—Saquinavir—acquired immunodeficiency syndrome	0.000137	0.00162	CcSEcCtD
Pseudoephedrine—Nausea—Lamivudine—acquired immunodeficiency syndrome	0.000131	0.00154	CcSEcCtD
Pseudoephedrine—CYP2D6—brain—acquired immunodeficiency syndrome	0.00012	0.00211	CbGeAlD
Pseudoephedrine—ADRB2—Class A/1 (Rhodopsin-like receptors)—CXCR4—acquired immunodeficiency syndrome	5.4e-05	0.00063	CbGpPWpGaD
Pseudoephedrine—NFATC1—Immune System—HLA-B—acquired immunodeficiency syndrome	5.35e-05	0.000625	CbGpPWpGaD
Pseudoephedrine—TNF—Folate Metabolism—IL6—acquired immunodeficiency syndrome	5.29e-05	0.000617	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CCL3—acquired immunodeficiency syndrome	5.25e-05	0.000613	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	5.23e-05	0.00061	CbGpPWpGaD
Pseudoephedrine—ADRA2A—G alpha (i) signalling events—CXCR4—acquired immunodeficiency syndrome	5.22e-05	0.000609	CbGpPWpGaD
Pseudoephedrine—ADRA2A—G alpha (i) signalling events—CXCL12—acquired immunodeficiency syndrome	5.22e-05	0.000609	CbGpPWpGaD
Pseudoephedrine—ADRA1A—GPCRs, Class A Rhodopsin-like—CXCR4—acquired immunodeficiency syndrome	5.21e-05	0.000608	CbGpPWpGaD
Pseudoephedrine—IL2—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	5.19e-05	0.000605	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	5.15e-05	0.000601	CbGpPWpGaD
Pseudoephedrine—ADRA2A—GPCRs, Class A Rhodopsin-like—CCR2—acquired immunodeficiency syndrome	5.15e-05	0.000601	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	5.11e-05	0.000596	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling by GPCR—CCL3L1—acquired immunodeficiency syndrome	5.09e-05	0.000595	CbGpPWpGaD
Pseudoephedrine—ADRB1—GPCR ligand binding—CCL3—acquired immunodeficiency syndrome	4.94e-05	0.000577	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—CCL3—acquired immunodeficiency syndrome	4.88e-05	0.000569	CbGpPWpGaD
Pseudoephedrine—ADRA2A—GPCRs, Class A Rhodopsin-like—CXCR4—acquired immunodeficiency syndrome	4.84e-05	0.000565	CbGpPWpGaD
Pseudoephedrine—ADRB2—GPCR ligand binding—CCL3—acquired immunodeficiency syndrome	4.83e-05	0.000564	CbGpPWpGaD
Pseudoephedrine—MAOA—Metabolism—TAT—acquired immunodeficiency syndrome	4.8e-05	0.00056	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	4.8e-05	0.00056	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	4.8e-05	0.00056	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	4.78e-05	0.000557	CbGpPWpGaD
Pseudoephedrine—IL2—Immune System—CD40LG—acquired immunodeficiency syndrome	4.76e-05	0.000555	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CCR2—acquired immunodeficiency syndrome	4.75e-05	0.000554	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	4.71e-05	0.00055	CbGpPWpGaD
Pseudoephedrine—IL2—Immune System—CD8A—acquired immunodeficiency syndrome	4.71e-05	0.000549	CbGpPWpGaD
Pseudoephedrine—IL2—Immune System—CSF2—acquired immunodeficiency syndrome	4.71e-05	0.000549	CbGpPWpGaD
Pseudoephedrine—NFATC1—Disease—CCR5—acquired immunodeficiency syndrome	4.7e-05	0.000548	CbGpPWpGaD
Pseudoephedrine—IL2—Immune System—HLA-B—acquired immunodeficiency syndrome	4.53e-05	0.000528	CbGpPWpGaD
Pseudoephedrine—IL2—Cytokine Signaling in Immune system—IL6—acquired immunodeficiency syndrome	4.48e-05	0.000522	CbGpPWpGaD
Pseudoephedrine—ADRB1—GPCR ligand binding—CCR2—acquired immunodeficiency syndrome	4.47e-05	0.000522	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CXCR4—acquired immunodeficiency syndrome	4.47e-05	0.000521	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CXCL12—acquired immunodeficiency syndrome	4.47e-05	0.000521	CbGpPWpGaD
Pseudoephedrine—ADRB1—GPCRs, Class A Rhodopsin-like—CCR5—acquired immunodeficiency syndrome	4.41e-05	0.000515	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—CCR2—acquired immunodeficiency syndrome	4.41e-05	0.000515	CbGpPWpGaD
Pseudoephedrine—ADRB2—GPCR ligand binding—CCR2—acquired immunodeficiency syndrome	4.37e-05	0.00051	CbGpPWpGaD
Pseudoephedrine—ADRB2—GPCRs, Class A Rhodopsin-like—CCR5—acquired immunodeficiency syndrome	4.32e-05	0.000504	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	4.32e-05	0.000504	CbGpPWpGaD
Pseudoephedrine—TNF—Selenium Micronutrient Network—IL6—acquired immunodeficiency syndrome	4.2e-05	0.000491	CbGpPWpGaD
Pseudoephedrine—ADRB1—GPCR ligand binding—CXCL12—acquired immunodeficiency syndrome	4.2e-05	0.00049	CbGpPWpGaD
Pseudoephedrine—ADRB1—GPCR ligand binding—CXCR4—acquired immunodeficiency syndrome	4.2e-05	0.00049	CbGpPWpGaD
Pseudoephedrine—ADRB1—Class A/1 (Rhodopsin-like receptors)—CCL5—acquired immunodeficiency syndrome	4.2e-05	0.00049	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—CXCR4—acquired immunodeficiency syndrome	4.15e-05	0.000484	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—CXCL12—acquired immunodeficiency syndrome	4.15e-05	0.000484	CbGpPWpGaD
Pseudoephedrine—ADRB2—GPCR ligand binding—CXCR4—acquired immunodeficiency syndrome	4.11e-05	0.00048	CbGpPWpGaD
Pseudoephedrine—ADRB2—GPCR ligand binding—CXCL12—acquired immunodeficiency syndrome	4.11e-05	0.00048	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Platelet activation, signaling and aggregation—CSF2—acquired immunodeficiency syndrome	4.11e-05	0.000479	CbGpPWpGaD
Pseudoephedrine—ADRB2—Class A/1 (Rhodopsin-like receptors)—CCL5—acquired immunodeficiency syndrome	4.11e-05	0.000479	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling by GPCR—ACKR1—acquired immunodeficiency syndrome	4.11e-05	0.000479	CbGpPWpGaD
Pseudoephedrine—MAOA—Metabolism—AGPS—acquired immunodeficiency syndrome	4.08e-05	0.000476	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	4.06e-05	0.000474	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	4.06e-05	0.000474	CbGpPWpGaD
Pseudoephedrine—TNF—TNF alpha Signaling Pathway—IL6—acquired immunodeficiency syndrome	4.06e-05	0.000473	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling by GPCR—ACKR1—acquired immunodeficiency syndrome	4.02e-05	0.000469	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	4e-05	0.000467	CbGpPWpGaD
Pseudoephedrine—ADRA1A—GPCR ligand binding—CCL3—acquired immunodeficiency syndrome	4e-05	0.000467	CbGpPWpGaD
Pseudoephedrine—ADRA2A—G alpha (i) signalling events—CCL5—acquired immunodeficiency syndrome	3.97e-05	0.000463	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	3.92e-05	0.000457	CbGpPWpGaD
Pseudoephedrine—SLC6A4—SIDS Susceptibility Pathways—TNF—acquired immunodeficiency syndrome	3.81e-05	0.000445	CbGpPWpGaD
Pseudoephedrine—ADRB1—Class A/1 (Rhodopsin-like receptors)—CCR5—acquired immunodeficiency syndrome	3.78e-05	0.000441	CbGpPWpGaD
Pseudoephedrine—TNF—Toll-like Receptor Signaling Pathway—IL6—acquired immunodeficiency syndrome	3.74e-05	0.000436	CbGpPWpGaD
Pseudoephedrine—ADRA2A—GPCR ligand binding—CCL3—acquired immunodeficiency syndrome	3.72e-05	0.000434	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling by GPCR—CCL4—acquired immunodeficiency syndrome	3.71e-05	0.000433	CbGpPWpGaD
Pseudoephedrine—ADRB2—Class A/1 (Rhodopsin-like receptors)—CCR5—acquired immunodeficiency syndrome	3.7e-05	0.000432	CbGpPWpGaD
Pseudoephedrine—SLC6A2—SLC-mediated transmembrane transport—ALB—acquired immunodeficiency syndrome	3.69e-05	0.000431	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	3.65e-05	0.000426	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling by GPCR—CCL4—acquired immunodeficiency syndrome	3.63e-05	0.000424	CbGpPWpGaD
Pseudoephedrine—ADRA1A—GPCR ligand binding—CCR2—acquired immunodeficiency syndrome	3.62e-05	0.000422	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	3.6e-05	0.00042	CbGpPWpGaD
Pseudoephedrine—ADRA2A—G alpha (i) signalling events—CCR5—acquired immunodeficiency syndrome	3.58e-05	0.000417	CbGpPWpGaD
Pseudoephedrine—ADRA1A—GPCRs, Class A Rhodopsin-like—CCR5—acquired immunodeficiency syndrome	3.57e-05	0.000417	CbGpPWpGaD
Pseudoephedrine—ADRA1A—GPCR ligand binding—CXCL12—acquired immunodeficiency syndrome	3.4e-05	0.000397	CbGpPWpGaD
Pseudoephedrine—ADRA1A—GPCR ligand binding—CXCR4—acquired immunodeficiency syndrome	3.4e-05	0.000397	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CCL5—acquired immunodeficiency syndrome	3.4e-05	0.000396	CbGpPWpGaD
Pseudoephedrine—ADRA2A—GPCR ligand binding—CCR2—acquired immunodeficiency syndrome	3.36e-05	0.000392	CbGpPWpGaD
Pseudoephedrine—TNF—Spinal Cord Injury—IL6—acquired immunodeficiency syndrome	3.32e-05	0.000388	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling by GPCR—ACKR1—acquired immunodeficiency syndrome	3.32e-05	0.000388	CbGpPWpGaD
Pseudoephedrine—ADRA2A—GPCRs, Class A Rhodopsin-like—CCR5—acquired immunodeficiency syndrome	3.32e-05	0.000387	CbGpPWpGaD
Pseudoephedrine—NFATC1—Immune System—IFNG—acquired immunodeficiency syndrome	3.31e-05	0.000386	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	3.29e-05	0.000384	CbGpPWpGaD
Pseudoephedrine—SLC6A3—SLC-mediated transmembrane transport—ALB—acquired immunodeficiency syndrome	3.27e-05	0.000382	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	3.24e-05	0.000378	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—TAT—acquired immunodeficiency syndrome	3.21e-05	0.000374	CbGpPWpGaD
Pseudoephedrine—ADRB1—GPCR ligand binding—CCL5—acquired immunodeficiency syndrome	3.2e-05	0.000373	CbGpPWpGaD
Pseudoephedrine—NFATC1—Immune System—CD4—acquired immunodeficiency syndrome	3.2e-05	0.000373	CbGpPWpGaD
Pseudoephedrine—ADRA2A—GPCR ligand binding—CXCL12—acquired immunodeficiency syndrome	3.16e-05	0.000369	CbGpPWpGaD
Pseudoephedrine—ADRA2A—GPCR ligand binding—CXCR4—acquired immunodeficiency syndrome	3.16e-05	0.000369	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—CCL5—acquired immunodeficiency syndrome	3.16e-05	0.000368	CbGpPWpGaD
Pseudoephedrine—ADRB2—GPCR ligand binding—CCL5—acquired immunodeficiency syndrome	3.13e-05	0.000365	CbGpPWpGaD
Pseudoephedrine—MAOA—SIDS Susceptibility Pathways—TNF—acquired immunodeficiency syndrome	3.13e-05	0.000365	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	3.09e-05	0.00036	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling by GPCR—ACKR1—acquired immunodeficiency syndrome	3.09e-05	0.00036	CbGpPWpGaD
Pseudoephedrine—SLC6A4—SIDS Susceptibility Pathways—IL6—acquired immunodeficiency syndrome	3.08e-05	0.000359	CbGpPWpGaD
Pseudoephedrine—TNF—Adipogenesis—IL6—acquired immunodeficiency syndrome	3.08e-05	0.000359	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CCR5—acquired immunodeficiency syndrome	3.06e-05	0.000357	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	3.04e-05	0.000355	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	3.01e-05	0.000351	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling by GPCR—CCL4—acquired immunodeficiency syndrome	3e-05	0.000351	CbGpPWpGaD
Pseudoephedrine—NFATC1—Innate Immune System—IL6—acquired immunodeficiency syndrome	2.97e-05	0.000346	CbGpPWpGaD
Pseudoephedrine—NFATC1—Disease—CD4—acquired immunodeficiency syndrome	2.95e-05	0.000344	CbGpPWpGaD
Pseudoephedrine—NFATC1—Immune System—IL2—acquired immunodeficiency syndrome	2.94e-05	0.000343	CbGpPWpGaD
Pseudoephedrine—TNF—Regulation of toll-like receptor signaling pathway—IL6—acquired immunodeficiency syndrome	2.92e-05	0.00034	CbGpPWpGaD
Pseudoephedrine—ADRB1—GPCR ligand binding—CCR5—acquired immunodeficiency syndrome	2.88e-05	0.000336	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—CCR5—acquired immunodeficiency syndrome	2.84e-05	0.000332	CbGpPWpGaD
Pseudoephedrine—ADRB2—GPCR ligand binding—CCR5—acquired immunodeficiency syndrome	2.82e-05	0.000329	CbGpPWpGaD
Pseudoephedrine—IL2—Immune System—IFNG—acquired immunodeficiency syndrome	2.8e-05	0.000327	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling by GPCR—CCL4—acquired immunodeficiency syndrome	2.79e-05	0.000326	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	2.78e-05	0.000325	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—AGPS—acquired immunodeficiency syndrome	2.73e-05	0.000318	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Hemostasis—IFNA1—acquired immunodeficiency syndrome	2.71e-05	0.000316	CbGpPWpGaD
Pseudoephedrine—IL2—Immune System—CD4—acquired immunodeficiency syndrome	2.7e-05	0.000315	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Platelet activation, signaling and aggregation—ALB—acquired immunodeficiency syndrome	2.68e-05	0.000312	CbGpPWpGaD
Pseudoephedrine—TNF—SIDS Susceptibility Pathways—IL6—acquired immunodeficiency syndrome	2.66e-05	0.00031	CbGpPWpGaD
Pseudoephedrine—ADRA1A—GPCR ligand binding—CCL5—acquired immunodeficiency syndrome	2.59e-05	0.000302	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	2.54e-05	0.000296	CbGpPWpGaD
Pseudoephedrine—ADRB1—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	2.53e-05	0.000295	CbGpPWpGaD
Pseudoephedrine—MAOA—SIDS Susceptibility Pathways—IL6—acquired immunodeficiency syndrome	2.52e-05	0.000294	CbGpPWpGaD
Pseudoephedrine—SLC6A4—Circadian rythm related genes—IL6—acquired immunodeficiency syndrome	2.51e-05	0.000293	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	2.48e-05	0.00029	CbGpPWpGaD
Pseudoephedrine—ADRB2—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	2.47e-05	0.000288	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	2.43e-05	0.000283	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	2.43e-05	0.000283	CbGpPWpGaD
Pseudoephedrine—ADRA2A—GPCR ligand binding—CCL5—acquired immunodeficiency syndrome	2.4e-05	0.00028	CbGpPWpGaD
Pseudoephedrine—ADRB1—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	2.37e-05	0.000277	CbGpPWpGaD
Pseudoephedrine—ADRB1—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	2.37e-05	0.000277	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	2.37e-05	0.000277	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	2.37e-05	0.000277	CbGpPWpGaD
Pseudoephedrine—ADRA1A—GPCR ligand binding—CCR5—acquired immunodeficiency syndrome	2.33e-05	0.000272	CbGpPWpGaD
Pseudoephedrine—ADRB2—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	2.32e-05	0.000271	CbGpPWpGaD
Pseudoephedrine—ADRB2—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	2.32e-05	0.000271	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	2.29e-05	0.000268	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	2.24e-05	0.000262	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	2.19e-05	0.000256	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Platelet activation, signaling and aggregation—IL2—acquired immunodeficiency syndrome	2.17e-05	0.000253	CbGpPWpGaD
Pseudoephedrine—ADRA2A—GPCR ligand binding—CCR5—acquired immunodeficiency syndrome	2.17e-05	0.000253	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	2.16e-05	0.000252	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	2.16e-05	0.000252	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	2.15e-05	0.00025	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Hemostasis—CSF2—acquired immunodeficiency syndrome	2.12e-05	0.000247	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	2.11e-05	0.000246	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	2.11e-05	0.000246	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—TAT—acquired immunodeficiency syndrome	2.09e-05	0.000244	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	2.05e-05	0.000239	CbGpPWpGaD
Pseudoephedrine—ADRA1A—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	2.04e-05	0.000239	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	1.96e-05	0.000229	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	1.96e-05	0.000229	CbGpPWpGaD
Pseudoephedrine—ADRA1A—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	1.92e-05	0.000224	CbGpPWpGaD
Pseudoephedrine—ADRA1A—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	1.92e-05	0.000224	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	1.91e-05	0.000223	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—IL2—acquired immunodeficiency syndrome	1.9e-05	0.000222	CbGpPWpGaD
Pseudoephedrine—ADRA2A—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	1.9e-05	0.000222	CbGpPWpGaD
Pseudoephedrine—SLC6A2—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	1.88e-05	0.000219	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	1.86e-05	0.000217	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	1.82e-05	0.000213	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	1.82e-05	0.000213	CbGpPWpGaD
Pseudoephedrine—ADRB1—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	1.81e-05	0.000211	CbGpPWpGaD
Pseudoephedrine—ADRA2A—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	1.79e-05	0.000208	CbGpPWpGaD
Pseudoephedrine—ADRA2A—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	1.79e-05	0.000208	CbGpPWpGaD
Pseudoephedrine—ADRB1—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	1.78e-05	0.000208	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—AGPS—acquired immunodeficiency syndrome	1.78e-05	0.000207	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	1.77e-05	0.000207	CbGpPWpGaD
Pseudoephedrine—ADRB2—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	1.77e-05	0.000206	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	1.74e-05	0.000204	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	1.74e-05	0.000204	CbGpPWpGaD
Pseudoephedrine—ADRB2—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	1.74e-05	0.000203	CbGpPWpGaD
Pseudoephedrine—NFATC1—Immune System—IL6—acquired immunodeficiency syndrome	1.73e-05	0.000202	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	1.72e-05	0.000201	CbGpPWpGaD
Pseudoephedrine—SLC6A3—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	1.66e-05	0.000194	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	1.65e-05	0.000192	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	1.64e-05	0.000191	CbGpPWpGaD
Pseudoephedrine—ADRB1—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	1.63e-05	0.00019	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	1.62e-05	0.000189	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	1.62e-05	0.000189	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	1.62e-05	0.000189	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	1.6e-05	0.000187	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	1.6e-05	0.000187	CbGpPWpGaD
Pseudoephedrine—NFATC1—Disease—IL6—acquired immunodeficiency syndrome	1.6e-05	0.000186	CbGpPWpGaD
Pseudoephedrine—ADRB2—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	1.59e-05	0.000186	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	1.58e-05	0.000184	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	1.5e-05	0.000175	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	1.48e-05	0.000172	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	1.47e-05	0.000171	CbGpPWpGaD
Pseudoephedrine—ADRA1A—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	1.46e-05	0.000171	CbGpPWpGaD
Pseudoephedrine—IL2—Immune System—IL6—acquired immunodeficiency syndrome	1.46e-05	0.000171	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	1.45e-05	0.000169	CbGpPWpGaD
Pseudoephedrine—ADRA1A—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	1.44e-05	0.000168	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—acquired immunodeficiency syndrome	1.4e-05	0.000164	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Hemostasis—ALB—acquired immunodeficiency syndrome	1.38e-05	0.000161	CbGpPWpGaD
Pseudoephedrine—ADRA2A—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	1.36e-05	0.000159	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	1.36e-05	0.000158	CbGpPWpGaD
Pseudoephedrine—ADRA2A—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	1.34e-05	0.000156	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	1.33e-05	0.000155	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	1.33e-05	0.000155	CbGpPWpGaD
Pseudoephedrine—ADRA1A—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	1.32e-05	0.000154	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	1.31e-05	0.000153	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	1.27e-05	0.000149	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	1.27e-05	0.000149	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	1.25e-05	0.000145	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	1.25e-05	0.000145	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	1.23e-05	0.000144	CbGpPWpGaD
Pseudoephedrine—ADRA2A—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	1.22e-05	0.000143	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	1.21e-05	0.000142	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	1.21e-05	0.000141	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	1.2e-05	0.00014	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	1.13e-05	0.000131	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Hemostasis—IL2—acquired immunodeficiency syndrome	1.12e-05	0.000131	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—IL6—acquired immunodeficiency syndrome	1.12e-05	0.00013	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	1.11e-05	0.00013	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	1.1e-05	0.000128	CbGpPWpGaD
Pseudoephedrine—TNF—Developmental Biology—IL6—acquired immunodeficiency syndrome	1.06e-05	0.000123	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	1.03e-05	0.00012	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	1.03e-05	0.00012	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	1.02e-05	0.000119	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	9.69e-06	0.000113	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	9.58e-06	0.000112	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	9.58e-06	0.000112	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	9.55e-06	0.000111	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	9.48e-06	0.000111	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—IL6—acquired immunodeficiency syndrome	9.45e-06	0.00011	CbGpPWpGaD
Pseudoephedrine—ADRB1—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	9.4e-06	0.00011	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	9.34e-06	0.000109	CbGpPWpGaD
Pseudoephedrine—ADRB2—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	9.2e-06	0.000107	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	8.73e-06	0.000102	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	8.54e-06	9.97e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	8.54e-06	9.97e-05	CbGpPWpGaD
Pseudoephedrine—MAOA—Metabolism—ALB—acquired immunodeficiency syndrome	8.37e-06	9.77e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	8.35e-06	9.75e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	7.84e-06	9.15e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	7.72e-06	9.01e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	7.61e-06	8.88e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	7.29e-06	8.5e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	7.18e-06	8.38e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	7.07e-06	8.25e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	7.06e-06	8.24e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	6.91e-06	8.06e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	6.56e-06	7.66e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	6.42e-06	7.49e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—ALB—acquired immunodeficiency syndrome	5.59e-06	6.53e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—IL2—acquired immunodeficiency syndrome	5.05e-06	5.89e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	5.02e-06	5.86e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—IL2—acquired immunodeficiency syndrome	4.94e-06	5.76e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	4.91e-06	5.73e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—IL2—acquired immunodeficiency syndrome	4.08e-06	4.76e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	4.06e-06	4.74e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—IL2—acquired immunodeficiency syndrome	3.79e-06	4.43e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	3.77e-06	4.4e-05	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—ALB—acquired immunodeficiency syndrome	3.65e-06	4.25e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—IL6—acquired immunodeficiency syndrome	2.97e-06	3.46e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—IL6—acquired immunodeficiency syndrome	2.9e-06	3.39e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—IL6—acquired immunodeficiency syndrome	2.4e-06	2.8e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—IL6—acquired immunodeficiency syndrome	2.23e-06	2.6e-05	CbGpPWpGaD
